Mia Hedman

Efficacy and safety of pravastatin in children and adolescents with heterozygous familial hypercholesterolemia: a prospective clinical follow-up study.

M. Nuutinen, T. Matikainen, Saila Piippo, 2005, The Journal of clinical endocrinology and metabolism.

familial hypercholesterolemia: a prospective clinical follow-up study Efficacy and safety of pravastatin in children and adolescents with heterozygous

M. Nuutinen, T. Matikainen, Saila Piippo, 2005 .

Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy.

H. Gylling, T. Miettinen, Anna Ketomäki, 2006, The Journal of pediatrics.

Pharmacokinetics and Pharmacodynamics of Pravastatin in Pediatric and Adolescent Cardiac Transplant Recipients on a Regimen of Triple Immunosuppression

P. Neuvonen, M. Neuvonen, C. Holmberg, 2004, Clinical pharmacology and therapeutics.

Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemia

P. Neuvonen, M. Neuvonen, Mia Hedman, 2003, Clinical pharmacology and therapeutics.

Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.

P. Neuvonen, M. Niemi, M. Eichelbaum, 2006, British journal of clinical pharmacology.

Low HDL‐C predicts the onset of transplant vasculopathy in pediatric cardiac recipients on pravastatin therapy

J. Sundvall, M. Jauhiainen, C. Ehnholm, 2007, Pediatric transplantation.